Prenetics Global Limited (PRE)
Prenetics Global Limited operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Hong Kong, HK. The stock last traded at $18.64, down 1.94% on the session, giving a market capitalisation of $316.9M. On trailing twelve-month figures it carries a trailing P/E of -4.07, a net margin of -62.5%. Its beta of 0.25 implies it has historically moved less than the broad market.
As an investment holding company, Prenetics Global Limited specializes in providing diagnostic and genetic testing services. Its comprehensive product line features CircleDNA, a consumer-oriented genetic analysis solution, and the Circle HealthPod, an advanced health monitoring device. The Circle HealthPod facilitates rapid COVID-19 detection through nucleic acid amplification technology, suitable for both professional point-of-care and personal at-home use. Additionally, the company offers ColoClear, a non-invasive FIT-DNA screening test for colorectal cancer, and Circle SnapShot, a readily available at-home blood testing kit. Other diagnostic solutions in their portfolio include Circle Medical, Circle One, and F1x/Fem. Prenetics Global Limited was founded in 2014 and maintains its headquarters in Quarry Bay, Hong Kong.
Prenetics Global Limited is most often compared with the following Healthcare names: